Journal
PLACENTA
Volume 133, Issue -, Pages 23-31Publisher
W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2023.01.007
Keywords
Preeclampsia; CPT1A; EMT; PI3K/Akt/mTOR pathway
Ask authors/readers for more resources
This study found that Carnitine palmitoyltransferase 1A (CPT1A) was upregulated in preeclamptic placentas and its abnormal expression in HTR8/SVneo cells was associated with cell invasion and migration, but not proliferation, cell cycle, and apoptosis. The results also revealed that CPT1A inhibits the epithelial-mesenchymal transition (EMT) process of HTR8/SVneo cells through the PI3K/AKT/mTOR signaling pathway, thus participating in the pathogenesis of preeclampsia.
Introduction: Preeclampsia (PE) refers to a syndrome of new-onset hypertension with multisystem involvement and damage after 20 weeks of gestation. Defective placentation due to dysregulated behaviors of trophoblast cells is considered a predominant cause of PE. Methods: Immunofluorescence (if) and Western blot were used to detect the expression and localization of Carnitine palmitoyltransferase 1A (CPT1A) in placenta. CPT1A protein was overexpressed/knocked down in HTR8/SVneo cells by lentiviral/siRNA interference method. CCK-8 Assay, Western blot, flow cytometry, Wound healing and Transwell assay were used to detect the functional impact of CPT1A on HTR8/SVneo cells. Transcriptomics and bioinformatics analysis were used to predict the possible pathway of CPT1A participating in PE. Results: CPT1A was upregulated in preeclamptic placentas when compared with normal controls. The abnormal expression of CPT1A in HTR8/SVneo cells is associated with the invasion and migration of HTR8/SVneo cells but is not related to the proliferation, cycle, and apoptosis of HTR8/SVneo cells. The results of Transcriptomic and Western blots suggest that phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway are activated in the si-CPT1A-1796 group. Compared with the si-NC group, the epithelial-mesenchymal transition (EMT) process of HTR8/SVneo cells in the si-CPT1A-1796 group was significantly enhanced. Discussion: CPT1A may participate in the pathogenesis of PE by inhibiting the EMT process of HTR8/SVneo cells through the PI3K/AKT/mTOR signaling axis. Thus, the newly unveiled novel function of CPT1A in PE via the PI3K/Akt/mTOR pathway provides a novel insight into the pathogenesis of PE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available